COURSE OF PREGNANCY, CHILDBIRTH, MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS OF THE PLACENTA IN PREGNANT WOMEN WITH CORONAVIRUS DISEASE COVID-198

Authors

DOI:

https://doi.org/10.11603/mie.1996-1960.2022.3.13378

Keywords:

pregnancy, COVID-19, complications of pregnancy, complications of childbirth, D-dimer, C-reactive protein, procalcitonin, blood plasma

Abstract

Background. The purpose of the study: to establish the complications of the course of pregnancy, childbirth, histological and immunohistochemical features of the placenta in women with the coronavirus disease COVID-19.

Material and methods. A comprehensive clinical examination of 65 pregnant women aged 22 to 34 years was conducted. Two groups were formed: the main group consisted of pregnant women who were diagnosed with COVID-19 during pregnancy; the comparison group was made up of pregnant women who did not have concomitant coronavirus disease during pregnancy.

Results. As a result of the study, it was established that women who were diagnosed with COVID-19 in the second and third trimesters of pregnancy had more frequent complications of pregnancy, which were manifested by fetal distress, uterine fibroids, hypohydramnios or polyhydramnios, VUI, compared to pregnant women who did not suffer from coronavirus the disease At the same time, in the group of patients with COVID-19, a higher percentage of premature births, fetal distress, chorioamnionitis, and acute respiratory distress syndrome of the fetus was observed, and a high percentage of operative deliveries was noted. At the same time, along with the development of the acute phase of inflammation, which is evidenced by an increase in the level of C-reactive protein (CRP), microthrombotic complications were observed, which was indicated by a high level of D-dimer in the blood plasma. An elevated procalcitonin level in pregnant women with COVID-19 indicates the presence of a localized infection.

Conclusions. Pregnancy and childbirth complications were more common in pregnant women with COVID-19 compared to pregnant women without coronavirus infection. Timely diagnosis of complicated pregnancy and childbirth using dopplerometry, biophysical profile of the fetus, determination of PSA, D-dimer, procalcitonin contributes to pathogenetic treatment and prevention negative perinatal consequences.

References

Rai, P., Kumar, B. K., Deekshit, V. K., Karunasagar, I., & Karunasagar, I. (2021). Detection technologies and recent developments in the diagnosis of COVID-19 infection. Applied microbiology and biotechnology. 105(2), 441-455. DOI: 10.1007/s00253-020-11061-5. DOI: https://doi.org/10.1007/s00253-020-11061-5

Rasmussen, S. A., Kelley, C. F., Horton, J. P., Jamieson, D. J. (2021). Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know. Obstetrics and gynecology. 137(3), 408-414. DOI: 10.1097/ AOG.0000000000004290. DOI: https://doi.org/10.1097/AOG.0000000000004290

Wang, C. L., Liu, Y. Y., Wu, C. H., Wang, C. Y., Wang, C. H., & Long, C. Y. (2021). Impact of COVID-19 on Pregnancy. International journal of medical sciences. 18(3), 763-767. DOI: 10.7150/ ijms.49923. DOI: https://doi.org/10.7150/ijms.49923

Solano, M. E., Arck, P. C. (2020). Steroids, Pregnancy and Fetal Development. Frontiers in immunology. 10, 3017. DOI: 10.3389/ fimmu.2019.03017. DOI: https://doi.org/10.3389/fimmu.2019.03017

Jamieson, D. J., Rasmussen, S. A. (2022). An update on COVID-19 and pregnancy. American journal of obstetrics and gynecology. 226(2), 177-186. DOI: 10.1016/j.ajog.2021.08.054. DOI: https://doi.org/10.1016/j.ajog.2021.08.054

D'Souza, R., Ashraf, R., Rowe, H., Zipursky, J., Clarfield, L., Maxwell, C., Arzola, C., Lapinsky, S., Paquette, K., Murthy, S., Cheng, M. P., Malhame, I. (2021). Pregnancy and COVID-19: pharmacologic considerations. Ultrasound in obstetrics & gynecology: the official journal of the International Society ofUltrasound in Obstetrics and Gynecology. 57(2), 195203. DOI: 10.1002/uog.23116. DOI: https://doi.org/10.1002/uog.23116

Boguszewski, C. L., dos Santos, C. M., Sakamoto, K. S., Marini, L. C., de Souza, A. M., & Azevedo, M. (2012). A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas. Pituitary. 15(1), 44-49. DOI: 10.1007/ s11102-011-0339-7. DOI: https://doi.org/10.1007/s11102-011-0339-7

Dashraath, P., Wong, J., Lim, M., Lim, L. M., Li, S., Biswas, A., Choolani, M., Mattar, C., Su, L. L. (2020). Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. American journal of obstetrics and gynecology. 222(6), 521-531. DOI: 10.1016/j.ajog.2020.03.021. DOI: https://doi.org/10.1016/j.ajog.2020.03.021

Lindsay, K. L., Buss, C., Wadhwa, P. D., Entringer, S. (2019). The Interplay Between Nutrition and Stress in Pregnancy: Implications for Fetal Programming of Brain Development. Biological psychiatry. 85(2), 135149. DOI: 10.1016/j.biopsych.2018.06.021. DOI: https://doi.org/10.1016/j.biopsych.2018.06.021

Whitehead, C. L., Walker, S. P. (2020). Consider pregnancy in COVID-19 therapeutic drug and vaccine trials. Lancet. 395(10237), e92. DOI: 10.1016/S0140-6736(20)31029-1. DOI: https://doi.org/10.1016/S0140-6736(20)31029-1

De, A., Sachdeva, R., Bose, A., Malik, M., Jayachandran, N., Pal, R. (2018). Human Chorionic Gonadotropin Influences Systemic Autoimmune Responses. Frontiers in endocrinology. 9, 742. DOI: 10.3389/fendo.2018.00742. DOI: https://doi.org/10.3389/fendo.2018.00742

Rundquist, O., Nestor, C. E., Jenmalm, M. C., Hellberg, S., Gustafsson, M. (2022). ProgesteroneInhibits the Establishment of Activation-Associated Chromatin During TH1 Differentiation. Frontiers in immunology. 13, 835625. DOI: 10.3389/ fimmu.2022.835625. DOI: https://doi.org/10.3389/fimmu.2022.835625

Johnson, E. D., Schell, J. C., Rodgers, G. M. (2019). The D-dimer assay. American journal of hematology. 94(7), 833-839. DOI: 10.1002/ajh.25482. DOI: https://doi.org/10.1002/ajh.25482

Chi, J., Gong, W., Gao, Q. (2021). Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review. Archives of gynecology and obstetrics. 303(2), 337-345. DOI: 10.1007/s00404-020-05889-5. DOI: https://doi.org/10.1007/s00404-020-05889-5

Sharps, M. C., Hayes, D. J. L., Lee, S., Zou, Z., Brady, C. A., Almoghrabi, Y., Kerby, A., Tamber, K. K., Jones, C. J., Adams Waldorf, K. M., Heazell, A. E. P. (2020). A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection. Placenta, 101, 13-29. DOI: 10.1016/j. placenta.2020.08.018. DOI: https://doi.org/10.1016/j.placenta.2020.08.018

Published

2023-05-26

How to Cite

Dyadyk, O. O., & Fastovets O. Р. . (2023). COURSE OF PREGNANCY, CHILDBIRTH, MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS OF THE PLACENTA IN PREGNANT WOMEN WITH CORONAVIRUS DISEASE COVID-198. Medical Informatics and Engineering, (3), 60–68. https://doi.org/10.11603/mie.1996-1960.2022.3.13378

Issue

Section

Articles